Sort   by:  
 Page size 
TranscriptomicsMicroarray analysis of strain EG4 vs. Nipponbare
In the japonica rice strain Gimbozu EG4, the DNA transposon mPing is actively transposing to attain over 1,000 copies, whereas in Nipponbare, where this element is virtually silent and has only 50 copies. To analyze the impact of such a massive amplification of transposable element on gene regulatio...
ORGANISM(S): Oryza sativa Japonica Group 
2010-06-20 | E-GEOD-15021 | biostudies-arrayexpress
UnknownFournier gangrene is associated with increased length of stay and higher healthcare costs compared to non-perineal necrotizing soft tissue infections: a retrospective analysis of the National Inpatient Sample (2016–2020)
Not available
S-EPMC12345050 | biostudies-literature
UnknownComparisons between retinal vessel calibers and various optic disc morphologic parameters with different optic disc appearances: The Glaucoma Stereo Analysis Study.
Not available
S-EPMC8320981 | biostudies-literature
UnknownRecommendations for Updating Fever and Inflammation of Unknown Origin From a Modified Delphi Consensus Panel.
Not available
S-EPMC11222709 | biostudies-literature
UnknownParkinson's disease variant detection and disclosure: PD GENEration, a North American study.
Not available
S-EPMC11292896 | biostudies-literature
GenomicsInhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia [ChIP-Seq]
All-trans-retinoic acid (ATRA) has been successfully used in therapy of acute promyelocytic leukemia (APL), a cytogenetically distinct subtype of acute myeloid leukemia (AML) but the response of non-APL AML cases to ATRA-based treatment has been poor. Here we show that, via epigenetic reprogramming,...
ORGANISM(S): Homo sapiens 
2012-03-14 | E-GEOD-34725 | biostudies-arrayexpress
TranscriptomicsInhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia [Illumina HumanHT-12 gene expression array]
All-trans-retinoic acid (ATRA) has been successfully used in therapy of acute promyelocytic leukemia (APL), a cytogenetically distinct subtype of acute myeloid leukemia (AML) but the response of non-APL AML cases to ATRA-based treatment has been poor. Here we show that, via epigenetic reprogramming,...
ORGANISM(S): Homo sapiens 
2012-03-14 | E-GEOD-34672 | biostudies-arrayexpress
UnknownReal-World Data Analysis of Pembrolizumab Monotherapy for NSCLC Using Japanese Postmarketing All-Case Surveillance Data.
Not available
S-EPMC9579417 | biostudies-literature
Sort   by:  
 Page size